Hepatology News and Research

RSS

Hepatology is the branch of medicine that incorporates study of liver, gallbladder, biliary tree and pancreas as well as management of their disorders.

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis, a chronic and aggressive liver condition.

14 Sep 2018

New test to predict advanced fibrosis in people with NAFLD

A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.

12 Sep 2018

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Novartis, a leader in immuno-dermatology, announced today new data from a patient preference survey showing psoriasis patients want their treatment to go beyond just clear skin and safety.

12 Sep 2018

Innovative robotic system helps in removing large colorectal lesions without surgery

Each year, an estimated 140,000 individuals in the U.S. are diagnosed with colorectal cancer, a malignancy that often develops from a benign polyp into cancer over time.

7 Sep 2018

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

More and more adults - but also about 34 percent of obese children - suffer from non-alcoholic fatty liver disease. An unhealthy lifestyle with little physical activity and a diet high in fat, sugar and fructose and/or a genetic predisposition can be the underlying caus.

31 Aug 2018

CHLA researchers highlight need to include overweight subjects in metabolic research

Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism and body temperature control.

23 Aug 2018

Kidney transplantation can be safely performed using organs from patients who had HCV

Researchers at Loma Linda University Health found that kidney transplantation can be safely performed using organs testing positive for the hepatitis C virus antibody but negative for active viral infection.

23 Aug 2018

Researchers win multi-million Euro award to conduct research into liver disease

A team of researchers from the School of Immunology and Microbial Sciences and the Dental Institute has secured a multi-million Euro award to conduct research into liver disease.

16 Aug 2018

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers - those born between 1945-1965 - are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

27 Jul 2018

CellMax Life receives six U.S. patents for early cancer detection blood test

CellMax Life, enabling early cancer detection and management with affordable, non-invasive blood tests, announced today that six U.S. patents have been granted for its biomimetic platform CMx, which detects circulating tumor cells.

26 Jul 2018

Alcohol-related cirrhosis mortality on the rise among young adults

Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

19 Jul 2018

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.

12 Jul 2018

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

9 Jul 2018

Nonalcoholic fatty liver disease costs the U.S. healthcare system $32 billion annually

Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease.

3 Jul 2018

Hepatology News and Research

Further Reading

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

New test to predict advanced fibrosis in people with NAFLD

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Innovative robotic system helps in removing large colorectal lesions without surgery

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

CHLA researchers highlight need to include overweight subjects in metabolic research

Kidney transplantation can be safely performed using organs from patients who had HCV

Researchers win multi-million Euro award to conduct research into liver disease

Researchers emphasize need for baby boomers to get tested for hepatitis C

CellMax Life receives six U.S. patents for early cancer detection blood test

Alcohol-related cirrhosis mortality on the rise among young adults

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

Nonalcoholic fatty liver disease costs the U.S. healthcare system $32 billion annually

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Antidepressant drug appears to effectively stop progression of PBC

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

MSU scientists discover early cause of intestinal inflammation

Genetically engineered bacteria shows promise as new treatment for constipation

Video consultations boost survival rates of liver disease patients, study finds

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News